MEDICAMEN Biotech Limited (MBL) is committed to providing quality medicines at an affordable cost through relentless pursuit of excellence in its operations, product quality, documentation and service.
Committed to providing solutions to the pharmaceutical industry across the value chain Over the last decade, Medicamen has emerged as an integrated Pharmaceutical and Life Sciences Solution Provider offering products & services to its customers across the world.
Cancer care refers to the medical treatment, management, and support provided to individuals diagnosed with cancer.
Cardiology is the branch of medicine that deals with the diagnosis and treatment of heart-related diseases and disorders.
CNS (Central Nervous System): The CNS is a crucial part of the nervous system that includes the brain and spinal cord.
Diabetology is the specialized field of medicine that focuses on the study, diagnosis, and management of diabetes mellitus.
Anti-malarials are drugs used to prevent and treat malaria, a mosquito-borne infectious disease caused by Plasmodium parasites.
Vitamins are organic compounds that are essential for the proper functioning of the body. They play crucial roles in various ...
Antibiotics are a class of medications used to treat bacterial infections. They work by killing or inhibiting the growth of bacteria...
Pain is an unpleasant sensory and emotional experience associated with actual or potential tissue damage.
CEO
Best service ever! Sam takes his time, with each client, providing utmost care, kindness, and concern. Friendly staff.
CTO
We have always received the absolute best service here, the staff help extremely fast.
Medicamen Biotech filed its first Abbreviated New Drug Application in eCTD format for ‘BORTEZOMIB FOR injection 3.5 MG/VIAL’ with the US Food and Drug Administration
Medicamen ने US फूड एंड ड्रग एडमिनिस्ट्रेशन (USFDA) के साथ BORTEZOMIB इंजेक्शन के लिए अपना पहला Abbreviated न्यूज ड्रग एप्लिकेशन (ANDA) दायर किया है। कंपनी ने 19 जुलाई को एक्सचेंजों को एक फाइलिंग के माध्यम से यह जानकारी दी
Medicamen stated that this represents a significant achievement for the company, which will eventually lead to a USFDA Audit.
Ninad Ramdasi / 30-Dec, 2021 / Categories: Interviews, DSIJ_Magazine_Web, Interview, DSIJMagazine_App, Regular Columns, Interviews
Copyright © 2023, MEDICAMEN BIOTECH LIMITED. All Rights Reserved. Designed by Rautela Tech